Implementation of the PPC-17 survey to identify children aged 8-17 years at risk of suffering from school bullying: a quantitative, descriptive, cross-sectional study in French primary care.

Messaadi, Nassir; Zerhoui, Lotfallah; Vincent, Camille; Charef, Linda; Richebe, Teddy; Leruste, Sébastien; Bayen, Marc; Bury, Ingrid et al. · BJGP Open · 2026

cross_sectional · Level IV

Where this comes from

Abstract

School bullying (SB) is an important public health issue with profound mental and physical health consequences. In France, data are lacking regarding the prevalence and detection of SB among children seen in primary care settings. To assess the prevalence of children aged 8-17 years at risk of SB consulting GPs, using the PPC-17 (persécution par les camarades; persecution by colleagues) screening tool. A quantitative, descriptive, cross-sectional study in 13 general practices in France. Between January and May 2023, children consulting their GP (accompanied by a parent) completed the 17-item self-administered PPC-17 questionnaire. A positive risk screening was defined as at least one 'often' response. GPs recorded the initial consultation reason. Data were analysed using univariate and bivariate statistics. Of 248 responders, 52.8% (<i>n</i> = 131) were girls and 34.7% (<i>n</i> = 86) were identified at risk of SB. Boys scored higher for physical violence (mean 4.3, standard deviation [SD] 4.2) while girls had higher scores for psychological violence (mean 7.4, SD 6.1); older girls (aged 13-17 years) had the highest psychological violence scores; boys aged 8-12 years the highest physical violence scores. Psychiatric symptoms were rarely given as the reason for consulting (17th most common reason out of 23). Children at higher risk were younger on average (mean age 11.7 years versus 12.8 years, <i>P</i><0.003). More than one-third of children consulting GPs were at risk of SB. The PPC-17 enables effective screening during routine consultations and reveals distinct gender and age patterns. Systematic integration of SB screening in primary care could enhance early identification and support.